Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Doxazosin 4mg modified-release tablets |
| BNF code | 0205040D0AAAQAQ |
| Virtual Therapeutic Moiety | Doxazosin |
| Date identifier became valid | 23 Sep 2020 |
| Previous product identifier | 134456001 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Doxazosin mesilate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372508002 |
| Strength value numerator | 4.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Cardura XL 4mg tablets (Viatris UK Healthcare Ltd) | |
| Doxadura XL 4mg tablets (Dexcel-Pharma Ltd) | |
| Larbex XL 4mg tablets (Teva UK Ltd) | |
| Raporsin XL 4mg tablets (Accord-UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Doxazosin 4mg modified-release tablets 28 tablet | |
| Doxazosin 4mg modified-release tablets 98 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.